Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 17, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • vaccine doses

Tag: vaccine doses

  • BiotechToday
  • World

Longer gap between vaccine doses: Effective or not?

BioTech Today July 8, 2021July 7, 2021

Anjali Kumari, IILM College of Engineering and Technology Longer gap (up to 45 weeks) between the Covid-19 vaccines may increase the immune response. According to a new study from the University of Oxford in the United Kingdom, it has been stated that a gap of up to 45 weeks between the first and second doses […]

Read More
  • BiotechToday
  • World

Moderna’s mRNA–1273 granted emergency use authorization by FDA

bioxone December 28, 2020December 28, 2020 2

Prama Ghosh, Amity University Kolkata The Food and Drug Administration announced granted emergency use authorization to Moderna’s mRNA–1273, it’s COVID-19 vaccine for use in individuals 18 and older Friday night, the second vaccination against the coronavirus in the United States one week after the agency authorized a similar vaccine from Pfizer and BioNTech. Moderna’s vaccine […]

Read More
  • BiotechToday
  • World

A vaccine to cure both yellow fever and COVID – 19?

bioxone December 7, 2020December 7, 2020 1

Prama Ghosh, Amity University Kolkata Based on the vaccine against yellow fever, a team of researchers led by Professor Johan Neyts and Kai Dallmeier at Rega Institute at KU Leuven, Belgium, have developed a vaccine candidate against Covid-19 which also works against yellow fever. Results indicate that the vaccine is effective in hamsters and monkeys […]

Read More
  • BiotechToday
  • World

Moderna requests emergency authorization from FDA for mRNA – 1273

bioxone December 1, 2020December 1, 2020 1

Prama Ghosh, Amity University Kolkata The Cambridge, Massachusetts – based Biotech Company, Moderna asked for emergency authorization from the U.S. Food and Drug Administration to use its COVID – 19 vaccines, mRNA – 1273, after receiving confirmation about its safety and efficacy on Monday. According to a new study, the shots offer a strong protection […]

Read More

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy